粥样硬化-话题@MedSci

#粥样硬化#

450篇内容 | 6366人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1944407, encodeId=c4f2194440e47, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=《动脉粥样硬化性心血管疾病管理血胆固醇治疗亚洲共识》即将发布，一起先睹为快！, objectType=article, longId=68945, objectId=ed2a6894558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed2a6894558, replyNumber=0, likeNumber=56, createdTime=2016-10-16, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed2a6894558, moduleTitle=《动脉粥样硬化性心血管疾病管理血胆固醇治疗亚洲共识》即将发布，一起先睹为快！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed2a6894558)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944433, encodeId=5e551944433e3, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Diabetes Care：高级糖基化终末产物、氧化产物和动脉粥样硬化程度相关性分析, objectType=article, longId=88652, objectId=dab18865241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dab18865241, replyNumber=0, likeNumber=62, createdTime=2017-12-08, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dab18865241, moduleTitle=Diabetes Care：高级糖基化终末产物、氧化产物和动脉粥样硬化程度相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dab18865241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944448, encodeId=65a3194444814, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Circulation： P2X7敲除抑制斑块内炎症小体活性并改善小鼠动脉粥样硬化, objectType=article, longId=95386, objectId=ad2095386b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad2095386b1, replyNumber=0, likeNumber=90, createdTime=2018-01-11, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad2095386b1, moduleTitle=Circulation： P2X7敲除抑制斑块内炎症小体活性并改善小鼠动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad2095386b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944414, encodeId=039b194441466, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布, objectType=article, longId=74240, objectId=2639e42408c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2639e42408c, replyNumber=0, likeNumber=18, createdTime=2017-03-08, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2639e42408c, moduleTitle=2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2639e42408c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944423, encodeId=06981944423ff, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Nat Commun：双基因激活或和动脉粥样硬化发生直接相关, objectType=article, longId=81649, objectId=8f0781649d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f0781649d1, replyNumber=0, likeNumber=80, createdTime=2017-03-21, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f0781649d1, moduleTitle=Nat Commun：双基因激活或和动脉粥样硬化发生直接相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f0781649d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944429, encodeId=7fc0194442967, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）, objectType=article, longId=86894, objectId=d80d86894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d80d86894a4, replyNumber=0, likeNumber=17, createdTime=2017-04-20, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d80d86894a4, moduleTitle=血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d80d86894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944417, encodeId=6d9f194441edb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=【盘点】2016动脉粥样硬化研究亮点（top10）, objectType=article, longId=78521, objectId=362ee8521bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=362ee8521bb, replyNumber=0, likeNumber=81, createdTime=2016-12-21, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=362ee8521bb, moduleTitle=【盘点】2016动脉粥样硬化研究亮点（top10）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=362ee8521bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944420, encodeId=b3ca1944420ce, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=JACC：Canakinumab对动脉粥样硬化患者的血管结构或功能无显著影响, objectType=article, longId=79950, objectId=078fe9950a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=078fe9950a5, replyNumber=0, likeNumber=76, createdTime=2017-02-19, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=078fe9950a5, moduleTitle=JACC：Canakinumab对动脉粥样硬化患者的血管结构或功能无显著影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=078fe9950a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944432, encodeId=71c8194443229, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Circulation：动脉粥样硬化中的重要环节！, objectType=article, longId=88187, objectId=1f388818e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f388818e03, replyNumber=0, likeNumber=120, createdTime=2017-03-05, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f388818e03, moduleTitle=Circulation：动脉粥样硬化中的重要环节！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f388818e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944404, encodeId=25a71944404f3, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Stroke: 美国社区老人颅内动脉粥样硬化狭窄的发生率, objectType=article, longId=66349, objectId=c04066349ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c04066349ae, replyNumber=0, likeNumber=64, createdTime=2017-03-16, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c04066349ae, moduleTitle=Stroke: 美国社区老人颅内动脉粥样硬化狭窄的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c04066349ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944428, encodeId=b32a19444286e, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=新研究成果为动脉粥样硬化的治疗找到新靶标, objectType=article, longId=85790, objectId=261785e90fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261785e90fd, replyNumber=0, likeNumber=85, createdTime=2017-05-13, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261785e90fd, moduleTitle=新研究成果为动脉粥样硬化的治疗找到新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=261785e90fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944421, encodeId=11c119444216f, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林, objectType=article, longId=81398, objectId=0d7181398c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d7181398c2, replyNumber=0, likeNumber=61, createdTime=2017-06-17, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d7181398c2, moduleTitle=Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d7181398c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944406, encodeId=8ac219444065c, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Thyroid ：放射性碘治疗并不会增加动脉粥样硬化的发生风险, objectType=article, longId=67775, objectId=cd386e7754f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd386e7754f, replyNumber=0, likeNumber=84, createdTime=2016-09-20, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd386e7754f, moduleTitle=Thyroid ：放射性碘治疗并不会增加动脉粥样硬化的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd386e7754f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944422, encodeId=3f2c19444226b, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Circulation：中国-PAR计划——制定我国10年动脉粥样硬化心血管病的预测模型, objectType=article, longId=81461, objectId=c76581461ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c76581461ba, replyNumber=0, likeNumber=82, createdTime=2016-12-31, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c76581461ba, moduleTitle=Circulation：中国-PAR计划——制定我国10年动脉粥样硬化心血管病的预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c76581461ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944415, encodeId=f6911944415c9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=J Am Acad Dermatol：化脓性汗腺炎与亚临床动脉粥样硬化, objectType=article, longId=74604, objectId=ffeae460452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffeae460452, replyNumber=0, likeNumber=66, createdTime=2017-04-11, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffeae460452, moduleTitle=J Am Acad Dermatol：化脓性汗腺炎与亚临床动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffeae460452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944418, encodeId=0eba19444189e, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=SCI TRANSL MED：预防动脉粥样硬化的新方法——补充棕榈油酸, objectType=article, longId=78994, objectId=76efe89943d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76efe89943d, replyNumber=0, likeNumber=57, createdTime=2017-01-06, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76efe89943d, moduleTitle=SCI TRANSL MED：预防动脉粥样硬化的新方法——补充棕榈油酸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76efe89943d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944419, encodeId=5d12194441926, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世, objectType=article, longId=79680, objectId=0b07e9680d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b07e9680d3, replyNumber=0, likeNumber=62, createdTime=2016-12-02, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b07e9680d3, moduleTitle=Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b07e9680d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944408, encodeId=966b1944408c5, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系, objectType=article, longId=68990, objectId=3d4a689900d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4a689900d, replyNumber=0, likeNumber=57, createdTime=2016-11-03, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4a689900d, moduleTitle=Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4a689900d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944396, encodeId=33fc1944396b6, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Diabetes Care：阿格列汀可减缓2型糖尿病的颈动脉粥样硬化进展(SPEAD-A), objectType=article, longId=60868, objectId=950860868f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=950860868f1, replyNumber=0, likeNumber=66, createdTime=2016-10-08, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=950860868f1, moduleTitle=Diabetes Care：阿格列汀可减缓2型糖尿病的颈动脉粥样硬化进展(SPEAD-A), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=950860868f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1944411, encodeId=5b99194441111, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, objectTitle=Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变, objectType=article, longId=72888, objectId=f5abe2888ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5abe2888ec, replyNumber=0, likeNumber=100, createdTime=2017-02-20, rootId=0, userName=huangshifeng, userId=b30d401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5abe2888ec, moduleTitle=Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5abe2888ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

粥样硬化

2020-05-29

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

《动脉粥样硬化性心血管疾病管理血胆固醇治疗亚洲共识》即将发布，一起先睹为快！

2016-10-16

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Diabetes Care：高级糖基化终末产物、氧化产物和动脉粥样硬化程度相关性分析

2017-12-08

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Circulation： P2X7敲除抑制斑块内炎症小体活性并改善小鼠动脉粥样硬化

2018-01-11

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布

2017-03-08

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Nat Commun：双基因激活或和动脉粥样硬化发生直接相关

2017-03-21

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）

2017-04-20

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

【盘点】2016动脉粥样硬化研究亮点（top10）

2016-12-21

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

JACC：Canakinumab对动脉粥样硬化患者的血管结构或功能无显著影响

2017-02-19

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Circulation：动脉粥样硬化中的重要环节！

2017-03-05

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Stroke: 美国社区老人颅内动脉粥样硬化狭窄的发生率

2017-03-16

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

新研究成果为动脉粥样硬化的治疗找到新靶标

2017-05-13

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林

2017-06-17

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Thyroid ：放射性碘治疗并不会增加动脉粥样硬化的发生风险

2016-09-20

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Circulation：中国-PAR计划——制定我国10年动脉粥样硬化心血管病的预测模型

2016-12-31

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

J Am Acad Dermatol：化脓性汗腺炎与亚临床动脉粥样硬化

2017-04-11

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

SCI TRANSL MED：预防动脉粥样硬化的新方法——补充棕榈油酸

2017-01-06

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世

2016-12-02

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系

2016-11-03

智者为医08 (审核中...)

前往app查看评论内容

#粥样硬化#

Diabetes Care：阿格列汀可减缓2型糖尿病的颈动脉粥样硬化进展(SPEAD-A)

2016-10-08

huangshifeng (审核中...)

前往app查看评论内容

#粥样硬化#

Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变

2017-02-20

科室
- - 订阅+
  - 更多科室
工具
服务